Application | Comment | Organism |
---|---|---|
pharmacology | structure of the enzyme guides the design of novel therapeutics against the methicillin-resistant pathogen | Staphylococcus aureus |
Cloned (Comment) | Organism |
---|---|
expressed in Escherichia coli BL21 (DE3), pET11a expression vector | Staphylococcus aureus |
Crystallization (Comment) | Organism |
---|---|
X-ray data-collection statistics, best crystal diffracting to beyond 1.45 A resolution | Staphylococcus aureus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Staphylococcus aureus | Q6GH13 | methicillin-resistent MRSA252 strain | - |
Staphylococcus aureus MRSA252 | Q6GH13 | methicillin-resistent MRSA252 strain | - |
Purification (Comment) | Organism |
---|---|
gel filtration, SDS-PAGE | Staphylococcus aureus |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
archetypal subunit orientation in the crystal structure of other dihydrodipicolinate synthase enzymes not observed, structure refinement will provide information regarding the structural evolution of dihydrodipicolinate synthase and the design of antibiotics targeting lysine biosynthesis in Staphylococcus aureus | Staphylococcus aureus |
Synonyms | Comment | Organism |
---|---|---|
MRSA-DHDPS | - |
Staphylococcus aureus |